Steroid-resistant nephrotic syndrome: genes and variants
Explore variant evidence for Steroid-resistant nephrotic syndrome across 2 analyzed proteins (NPHS2, COL4A5). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Steroid-resistant nephrotic syndrome
NPHS2: Podocin
It organizes nephrin-containing slit-diaphragm complexes in podocytes and helps maintain the glomerular filtration barrier. Biallelic pathogenic variants are a major cause of steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis.
8 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in NPHS2 have source records linked to Steroid-resistant nephrotic syndrome. Association strength is not clinical gene validity.
COL4A5: Collagen alpha-5(IV) chain
It is essential for the alpha3-alpha4-alpha5 type IV collagen network that gives glomerular and cochlear basement membranes their mature mechanical properties. Pathogenic variants cause X-linked Alport syndrome, with progressive kidney disease, hearing loss, and characteristic ocular findings.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in COL4A5 have source records linked to Steroid-resistant nephrotic syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): APOL1, COL4A3, COL4A4 and GLA.
ClinVar pathogenic and likely pathogenic variants linked to Steroid-resistant nephrotic syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NPHS2 R168C | 168 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 V260E | 260 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 A297V | 297 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 E310K | 310 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 R322G | 322 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 V180M | 180 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 E281K | 281 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| NPHS2 R138Q | 138 | Cytoplasmic | Pathogenic / likely pathogenic |
| COL4A5 P225L | 225 | Triple-helical region | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Steroid-resistant nephrotic syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| NPHS2 R322P | 322 | Cytoplasmic | Conflicting reports (★) | +6: R322G at the same position is pathogenic; REVEL 0.959 |
Which prediction tools work for Steroid-resistant nephrotic syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- CADD: 96 out of 100
- MetaLR: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 93 out of 100
- SIFT: 89 out of 100
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 86 out of 100
- SpliceAI: 63 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 23 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Nephrotic syndrome also has ClinVar records linked to NPHS2 variants; they fall mostly in different places as the Steroid-resistant nephrotic syndrome variants (30 pathogenic / likely pathogenic).
- Idiopathic nephrotic syndrome also has ClinVar records linked to NPHS2 variants; they fall partly in the same places as the Steroid-resistant nephrotic syndrome variants (5 pathogenic / likely pathogenic).
- X-linked Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Steroid-resistant nephrotic syndrome variants (341 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Steroid-resistant nephrotic syndrome variants (14 pathogenic / likely pathogenic).
Diseases related to Steroid-resistant nephrotic syndrome
- Nephrotic syndrome, also linked to COL4A5 and NPHS2
- X-linked Alport syndrome, also linked to COL4A5
- Alport syndrome, also linked to COL4A5
- Autosomal dominant Alport syndrome, also linked to COL4A5
- Rare genetic deafness, also linked to COL4A5
- Finnish congenital nephrotic syndrome, also linked to NPHS2
- Monogenic hearing loss, also linked to COL4A5
- Idiopathic nephrotic syndrome, also linked to NPHS2
- Isolated macular dystrophy, also linked to COL4A5
- Focal segmental glomerulosclerosis, also linked to NPHS2
- Kidney disorder, also linked to COL4A5
Frequently asked questions
Which genes have records linked to Steroid-resistant nephrotic syndrome?
This view contains 2 analyzed proteins: NPHS2, COL4A5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 31 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center